INCIDENCE OF HEPATOTOXIC SIDE-EFFECTS DURING ANTITUBERCULOUS THERAPY (INH, RMP, EMB) IN RELATION TO THE ACETYLATOR PHENOTYPE

被引：23
作者：
MUSCH, E
EICHELBAUM, M
WANG, JK
VONSASSEN, W
CASTROPARRA, M
DENGLER, HJ
机构：
来源：
KLINISCHE WOCHENSCHRIFT | 1982年 / 60卷 / 10期
关键词：
D O I：
10.1007/BF01756097
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：513 / 519
页数：7
相关论文
共 34 条
[1]   KINETIC STUDIES ON RIFAMPICIN .1. SERUM CONCENTRATION ANALYSIS IN SUBJECTS TREATED WITH DIFFERENT ORAL DOSES OVER A PERIOD OF 2 WEEKS [J].
ACOCELLA, G ;
BARONI, GC ;
MARCHETTI, M ;
PAGANI, V ;
NICOLIS, FB .
CHEMOTHERAPY, 1971, 16 (06) :356-+
[2]  
[Anonymous], 1973, Tubercle, V54, P99
[3]  
BLACK M, 1975, GASTROENTEROLOGY, V69, P289
[4]  
Blanchon P, 1973, Poumon Coeur, V29, P739
[5]  
BRATTON AC, 1962, PRACTICAL CLIN BIOCH, P731
[6]  
Brouet G, 1969, Rev Tuberc Pneumol (Paris), V33, P27
[7]  
BURKE M, 1979, J JR MED ASS, V72, P430
[8]  
DICKINSON D S, 1977, American Review of Respiratory Disease, V115, P395
[9]   PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN [J].
ELLARD, GA ;
GAMMON, PT .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02) :83-113
[10]  
EVANS DAP, 1964, J LAB CLIN MED, V63, P394
1234